Active	Status	Sponsor type	Region	Phase	Filter
13 Active 17 Inactive 30 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Combs, Stephanie E
INTRAGO-II, NCT02685605: Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme	Active, not recruiting	3	314	Europe, Canada, US, RoW	Standard surgery, Intraoperative radiotherapy, IORT, Radiochemotherapy, Temozolomide	Universitätsmedizin Mannheim, Carl Zeiss Meditec AG, University of California, Los Angeles	Glioblastoma	06/24	06/26
NANORAY-312, NCT04892173 / 2021-002163-22: JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC	Recruiting	3	500	Europe, Japan, US, RoW	JNJ-90301900 (NBTXR3), Functionalized hafnium oxide nanoparticles, NBTXR3, Cetuximab, Erbitux, Radiation Therapy	Johnson & Johnson Enterprise Innovation Inc., Nanobiotix SA	Locally Advanced Head and Neck Squamous Cell Carcinoma, Aged	06/26	06/27
Diehl, Dyer M
No trials found
Staples, William H
No trials found
Schmid, Arlene A
No trials found
Combs-Miller, Stephanie A
No trials found
Miller, Stephanie
No trials found